Literature DB >> 32078179

Dopaminergic depletion, β-amyloid burden, and cognition in Lewy body disease.

Han Soo Yoo1, Sangwon Lee2, Seok Jong Chung1, Yang Hyun Lee1, Phil Hyu Lee1, Young H Sohn1, Seungyeoun Lee3, Mijin Yun2, Byoung Seok Ye1.   

Abstract

OBJECTIVE: We aimed to determine the association between striatal dopaminergic depletion, cerebral β-amyloid deposition, and cognitive dysfunction in Lewy body disease (LBD).
METHODS: This cross-sectional study recruited 48 LBD patients (30 with dementia and 18 with mild cognitive impairment) and 15 control subjects from a university-based hospital. We measured the striatal dopamine transporter (DAT) activity and regional β-amyloid burden using18 F-FP-CIT positron emission tomography (PET) and 18 F-florbetaben (FBB) PET, respectively. The relationship between striatal FP-CIT uptake, regional cortical FBB uptake, and cognitive function scores was evaluated using path analyses. We also investigated the effects of striatal FP-CIT uptake and cortical FBB uptake on the interval between motor symptom and dementia onset.
RESULTS: Reduced striatal FP-CIT uptake was associated with increased FBB uptake in the posterior cortical regions, most prominently in the occipital cortices. Reduced FP-CIT uptake in the anterior putamen was associated with visuospatial dysfunction with mediation of increased occipital FBB uptake. Reduced FP-CIT uptake in the posterior putamen and an increased parietal FBB uptake were independently associated with memory dysfunction. Reduced striatal FP-CIT uptake was associated with attention, language, and frontal/executive dysfunction, independent of amyloid deposition. Increased FBB uptake, especially in the parietal cortex, was associated with earlier onset of dementia.
INTERPRETATION: Our results suggest that occipital β-amyloid deposition may contribute to the association between striatal dopaminergic depletion and visuospatial dysfunction in LBD patients. Although the effects of reduced DAT activity are more prominent than those of β-amyloid burden on cognitive dysfunction, the latter affects the onset of cognitive dysfunction. This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.

Entities:  

Year:  2020        PMID: 32078179     DOI: 10.1002/ana.25707

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  8 in total

1.  Significance of cerebral amyloid angiopathy and other co-morbidities in Lewy body diseases.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2021-04-29       Impact factor: 3.575

Review 2.  60 Years of Achievements by KSNM in Neuroimaging Research.

Authors:  Jae Seung Kim; Hye Joo Son; Minyoung Oh; Dong Yun Lee; Hae Won Kim; Jungsu Oh
Journal:  Nucl Med Mol Imaging       Date:  2022-01-15

3.  Association of β-Amyloid and Basal Forebrain With Cortical Thickness and Cognition in Alzheimer and Lewy Body Disease Spectra.

Authors:  Han Soo Yoo; Seun Jeon; Enrica Cavedo; MinJin Ko; Mijin Yun; Phil Hyu Lee; Young H Sohn; Michel J Grothe; Stefan Teipel; Harald Hampel; Alan C Evans; Byoung Seok Ye
Journal:  Neurology       Date:  2021-12-30       Impact factor: 9.910

Review 4.  Novel Tracers and Radionuclides in PET Imaging.

Authors:  Christian Mason; Grayson R Gimblet; Suzanne E Lapi; Jason S Lewis
Journal:  Radiol Clin North Am       Date:  2021-09       Impact factor: 1.947

5.  Brain Metabolism Related to Mild Cognitive Impairment and Phenoconversion in Patients With Isolated REM Sleep Behavior Disorder.

Authors:  Eun Jin Yoon; Jee-Young Lee; Heejung Kim; Dallah Yoo; Jung Hwan Shin; Hyunwoo Nam; Beomseok Jeon; Yu Kyeong Kim
Journal:  Neurology       Date:  2022-04-18       Impact factor: 11.800

6.  Quantification of Brain β-Amyloid Load in Parkinson's Disease With Mild Cognitive Impairment: A PET/MRI Study.

Authors:  Michela Garon; Luca Weis; Eleonora Fiorenzato; Francesca Pistonesi; Annachiara Cagnin; Alessandra Bertoldo; Mariagiulia Anglani; Diego Cecchin; Angelo Antonini; Roberta Biundo
Journal:  Front Neurol       Date:  2022-03-01       Impact factor: 4.003

7.  Effects of Alzheimer's genetic risk scores and CSF biomarkers in de novo Parkinson's Disease.

Authors:  Young-Gun Lee; Seong Ho Jeong; Mincheol Park; Sung Woo Kang; Kyoungwon Baik; Seun Jeon; Phil Hyu Lee; Young Ho Sohn; Byoung Seok Ye
Journal:  NPJ Parkinsons Dis       Date:  2022-05-11

8.  Interaction of CSF α-synuclein and amyloid beta in cognition and cortical atrophy.

Authors:  Young-Gun Lee; Seun Jeon; Sung Woo Kang; Mincheol Park; Kyoungwon Baik; Han Soo Yoo; Seok Jong Chung; Seong Ho Jeong; Jin Ho Jung; Phil Hyu Lee; Young Ho Sohn; Alan C Evans; Byoung Seok Ye
Journal:  Alzheimers Dement (Amst)       Date:  2021-05-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.